GGrantIndex
Sort

46,585 grants matching heart failure

Translational Study of Cardiac Dysfunction

$678,491
Nipavan Chiamvimonvat · University Of California At Davis · R01 · FY2019 · HL

Predicting and Monitoring for Cardiac Toxicity in Pediatric AML

$678,486
Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2025 · HL

C5ORF51 - a Novel Regulator of Cardiomyocyte Function and Homeostasis

$678,445
Ruya Liu · University Of Maryland Baltimore · R56 · FY2024 · HL

Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury

$678,416
Timothy Daniel O'Connell · University Of Minnesota · R01 · FY2021 · HL

Accelerating research to advance care for adults with congenital heart disease through development of validated scalable computational phenotypes

$678,400
Alexander R. Opotowsky · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL

Dzip1 and Mitral Valve Prolapse

$678,380
Russell Norris · Medical University Of South Carolina · R56 · FY2025 · HL

Patient Navigators: Secondary Prevention in Underserved Coronary Disease Patients

$678,358
Diane M Becker · Johns Hopkins University · R01 · FY2010 · NR

Ventricular arrhythmias and mechanisms of parasympathetic dysfunction following myocardial infarction

$678,343
Marmar Vaseghi · University Of California Los Angeles · R01 · FY2023 · HL

Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity

$678,320
Bonnie Ky · University Of Pennsylvania · R01 · FY2018 · HL

Age Associated Changes In Structural And Functional Cardio-Vascular Properties

$678,284
Edward Lakatta · National Institute On Aging · ZIA · FY2019 · AG

3D combinatorial microenvironments for effective cell based therapy

$678,207
Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2012 · HL

Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response

$678,171
Brian Jesse Debosch · Washington University · R01 · FY2021 · HL

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

$678,150
Jonathan Lee Slaughter · Research Inst Nationwide Children'S Hosp · R01 · FY2020 · HL

Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome

$678,054
Michael E Davis · Emory University · R01 · FY2019 · HL

Metabolic impact of FGF-21 in adipose tissue and liver of PLWH

$677,982
Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · DK

Cardiac MRI for Reperfusion Spatial Mapping to Improve Heart Failure Outcomes

$677,963
Kim-Lien T Nguyen · University Of California Los Angeles · R01 · FY2025 · HL

Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults

$677,939
Michael G Shlipak · Northern California Institute/Res/Edu · R01 · FY2022 · AG

Patterns of Cardiopulmonary health across the life course

$677,938
Sadiya Sana Khan · Northwestern University At Chicago · R01 · FY2023 · HL

COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.

$677,874
John A Dodson · New York University School Of Medicine · R01 · FY2023 · AG

Engineered Stem Cells for Cardiac Repair

$677,801
Michael Regnier · University Of Washington · R01 · FY2020 · HL

REDUCTION IN HOSPITALIZATIONS IN LOW-INCOME PATIENTS WITH HEART FAILURE

$677,767
Lynda H Powell · Rush University Medical Center · P50 · FY2010 · HL

Mesenchymal stem cell therapy for endothelial dysfunction in diabetes

$677,730
Ivonne H Schulman · University Of Miami School Of Medicine · R01 · FY2017 · HL

Structure function relationships from deep mutational scanning in human cardiomyopathy

$677,725
Euan A Ashley · Stanford University · R01 · FY2022 · HL

PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation

$677,686
Muhammad Ashraf · University Of Cincinnati · R01 · FY2011 · HL

Understanding and Eliminating Oncogenic EGFR Signaling in Malignant Glioma

$677,676
Alain Charest · Tufts Medical Center · U01 · FY2009 · CA